Abstract:1577 Objectives: To study stability and distribution of Poly(APMA)-DOTA-Copper nanoparticles in vivo by intratumoral injection of the nanoparticles conjugated with copper-64 radioisotope and subsequent microPET imaging. Methods: N-(3-aminopropyl) methacrylamide (APMA) nano-sized polymer was synthesized by free radical precipitation polymerization in acetone/DMSO using N,N’-azobis(isobutyronitrile) (AIBN) as the initiator. The poly(APMA) was characterized with nuclear magnetic resonance (NMR), size exclusion chromatography (SEC) and dynamic light scattering (DLC). Then 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) was conjugated with the poly(APMA) using 1-(3-dimetylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) as an activator. To assess stability and retention of the nanoparticles in the tumor tissues, the Poly(APMA)-DOTA nanoparticles conjugated with copper-64 chloride (64CuCl2) were directly injected to the human prostate cancer xenograft tissues in mice, followed by whole body imaging using a Concorde microPET R4 tomograph at 1 and 24 hours post injection of the nanoparticles. Results: Nano-sized poly(APMA)-DOTA polymers conjugated with 64Cu radionuclide were synthesized and characterized as a nano-sized particle (Mw ~3 KDa, effective diameter ~ 60 nm). Following intratumoral injection, the nanoparticles conjugated with 64Cu were localized in the human prostate cancer xenograft tissues with little leakage of the 64Cu radionuclide from the tumor to the normal mouse organs, as demonstrated by intense 64Cu signals in the region of the tumor xenograft on the microPET images and little radioactivity signals in the other regions of the mouse body. Conclusions: The nano-sized Poly(APMA)-DOTA polymer conjugated with a therapeutic β-emitter copper isotope, such as 67Cu, might be useful for radionuclide cancer therapy by interventional delivery of the nanoparticles to a tumor lesion. Research Support (if any): Research Development Award from Carman and Ann Adams Department of Pediatrics, Wayne State University

Renal-Clearable Ultrasmall Coordination Polymer Nanodots for Chelator-Free 64Cu-Labeling and Imaging-Guided Enhanced Radiotherapy of Cancer.

Ultra-small Iron-Gallic Acid Coordination Polymer Nanoparticles for Chelator-Free Labeling of 64cu and Multimodal Imaging-Guided Photothermal Therapy

Renal Clearable Ru-based Coordination Polymer Nanodots for Photoacoustic Imaging Guided Cancer Therapy.

Highly Effective Radioisotope Cancer Therapy with a Non-Therapeutic Isotope Delivered and Sensitized by Nanoscale Coordination Polymers

Chelator-free (64)Cu-Integrated Gold Nanomaterials for Positron Emission Tomography Imaging Guided Photothermal Cancer Therapy.

Renal‐Clearable PEGylated Porphyrin Nanoparticles for Image‐Guided Photodynamic Cancer Therapy

Acid-degradable Gadolinium-Based Nanoscale Coordination Polymer: A Potential Platform for Targeted Drug Delivery and Potential Magnetic Resonance Imaging

Core-Satellite Polydopamine-Gadolinium-Metallofullerene Nanotheranostics for Multimodal Imaging Guided Combination Cancer Therapy

Biocompatible Conjugated Polymer Nanoparticles Labeled with 225ac for Tumor Endoradiotherapy

Biocompatible Conjugated Polymer Nanoparticles Labeled with 225 Ac for Tumor Endoradiotherapy

Synthesis and Characterization of Nano-Sized Poly(APMA)-DOTA-Copper Conjugate for Radionuclide Cancer Therapy: Assessment of Stability and Distribution in Vivo by Micropet Imaging

Integrin Αvβ3-Targeted [64cu]cus Nanoparticles for PET/CT Imaging and Photothermal Ablation Therapy.

Ph‐sensitive Dissociable Nanoscale Coordination Polymers with Drug Loading for Synergistically Enhanced Chemoradiotherapy

Polydopamine Coated Single-Walled Carbon Nanotubes As a Versatile Platform with Radionuclide Labeling for Multimodal Tumor Imaging and Therapy

Self‐Assemble Polymeric Nanoparticle with GSH Exhaustion for SPECT Imaging–Guided Enhanced Radioisotope Therapy

Simultaneous multimodal imaging and photothermal therapy via renal-clearable manganese-doped copper sulfide nanodots

Acidity-Activated Charge Conversion of 177 Lu-Labeled Nanoagent for the Enhanced Photodynamic Radionuclide Therapy of Cancer

A Proof-of-Concept Study on the Theranostic Potential of 177Lu-Labeled Biocompatible Covalent Polymer Nanoparticles for Cancer Targeted Radionuclide Therapy

Ultrasmall Hyperbranched Semiconducting Polymer Nanoparticles with Different Radioisotopes Labeling for Cancer Theranostics

Radionuclide Imaging-Guided Chemo-Radioisotope Synergistic Therapy Using a 131I-Labeled Polydopamine Multifunctional Nanocarrier.

Biodegradable Nanoagents with Short Biological Half-Life for SPECT/PAI/MRI Multimodality Imaging and PTT Therapy of Tumors